Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ACTUS-101 by Asklepios BioPharmaceutical for Pompe Disease: Likelihood of Approval
ACTUS-101 is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Pompe Disease. According to GlobalData, Phase...
Data Insights
ACTUS-101 by Asklepios BioPharmaceutical for Pompe Disease: Likelihood of Approval
ACTUS-101 is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Pompe Disease. According to GlobalData, Phase...